Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Not Applicable

Recruiting

• Conditions: Pruritus

• Registration Number: NCT06751056
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-12-20
• Study First Submitted QC: 2024-12-20
• Study First Posted: 2024-12-27
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-19
• Last Update Posted: 2025-02-20
• Study Start: 2025-04-10
• Primary Completion: 2027-01-10
• Study Completion: 2027-01-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Change in GABAergic medication usage	Baseline, 12 weeks	Reported as percentage of reduction in dosage of gabapentin or pregabalin after 12 weeks of home neck traction.

Secondary Outcome Measures

Name	Time	Method
Pruritus Severity Score	Baseline, 14 days, 28 days, 42 days, 56 days, and 72 days	A 12-item questionnaire assessing different aspects of pruritus. The items are grouped into five domains: pruritus intensity, pruritus extent, frequency and duration of pruritus, impact of pruritus on daily activities and mood, and assessment of scratching. Total scoring ranges from 3 (the lowest pruritus intensity) to 22 points (the highest pruritus intensity).

Trial Locations

Locations (1)

Mayo Clinic in Arizona; 🇺🇸 Scottsdale, Arizona, United States